NT5E CpG island methylation is a favourable breast cancer biomarker

File Description SizeFormat 
NT5E CpG island methylation is a favourable breast cancer biomarker.pdfPublished version684.94 kBAdobe PDFView/Open
Title: NT5E CpG island methylation is a favourable breast cancer biomarker
Authors: Lo Nigro, C
Monteverde, M
Lee, S
Lattanzio, L
Vivenza, D
Comino, A
Syed, N
McHugh, A
Wang, H
Proby, C
Garrone, O
Merlano, M
Hatzimichael, E
Briasoulis, E
Gojis, O
Palmieri, C
Jordan, L
Quinlan, P
Thompson, A
Crook, T
Item Type: Journal Article
Issue Date: 31-May-2012
Date of Acceptance: 23-Apr-2012
URI: http://hdl.handle.net/10044/1/27128
DOI: https://dx.doi.org/10.1038/bjc.2012.212
ISSN: 1532-1827
Publisher: Cancer Research UK
Start Page: 75
End Page: 83
Journal / Book Title: British Journal of Cancer
Volume: 107
Issue: 1
Copyright Statement: © 2012 Cancer Research UK. This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
ONCOLOGY
NT5E
breast cancer
metastasis
epigenetics
triple-negative breast cancer
ECTO-5'-NUCLEOTIDASE CD73
GENE-EXPRESSION
PROGNOSTIC-FACTORS
ECTO-5-NUCLEOTIDASE
CELLS
RECURRENCE
METASTASES
MANAGEMENT
APOPTOSIS
MIGRATION
Publication Status: Published
Appears in Collections:Division of Surgery
Division of Cancer
Department of Medicine
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx